Journal
CHEST
Volume 158, Issue 1, Pages 206-211Publisher
ELSEVIER
DOI: 10.1016/j.chest.2019.11.019
Keywords
critical care; mortality outcomes; neutral trials; patient-important outcomes; randomized controlled trials
Categories
Funding
- Southeastern Ontario Academic Medical Organization (SEAMO)
Ask authors/readers for more resources
Mortality has long been used as a primary end point for randomized controlled trials in critical care. Recently, a plurality of trials targeting mortality end points as their primary outcome has failed to detect a difference between study arms. While there are a number of reasons for the preponderance of such neutral trials, the use of mortality as an outcome is one important consideration. We explore some of the reasons why such trials may be biased toward a neutral result, as well as reasons to consider alternative end points that are better coupled to the expected therapeutic effect. We also discuss to what extent mortality as a binary outcome is patient-important in the ICU.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available